百特国际（BAX）今日盘中大幅拉升，涨幅高达19.64%，引起市场广泛关注。
消息面上，公司于盘前发布了第二季度财报，业绩表现远超市场预期。数据显示，百特国际第二季度调整后每股收益为0.54美元，大幅超越市场一致预期的0.37美元，超出幅度达45.95%；营收达29.6亿美元，同样高于分析师预期的27.95亿美元。业绩超预期主要得益于静脉注射液等医疗产品的强劲销售，其最大的医疗产品和疗法业务部门（包括静脉输液）第二季度销售额同比增长7%，达到20.8亿美元。
此外，百特国际同步上调了年度利润预期，将2026年调整后每股收益指引从此前的1.85至2.05美元上调至1.95至2.15美元，进一步提振了市场信心。近期多家投行也集中上调了百特的目标价，其中Stifel将目标价从19美元上调至24美元，Evercore ISI上调至24美元，高盛上调至21美元，均反映出市场对公司经营改善趋势的认可。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.